Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investors

Indian pharma stocks declined after reports of Donald Trump's proposed 100 percent tariff on generic drugs, with the Nifty Pharma index falling 1.3 percent while the Nifty 50 dropped 0.8 percent. Lupin led the losses at 4.3 percent, followed by Piramal Pharma, Ajanta Pharma, Aurobindo Pharma, Alembic Pharmaceuticals, and Granules India, which declined between 2.5 and 4.2 percent. Analysts warned that Indian pharma firms with US revenue exposure would be most impacted, though the move remains preliminary and could face negotiations.